1	El	el	DA0MS0	-	-	0-2	610(0)_ANS_clinical_caseMIR	SENT1	-	-
2	nivel	nivel	NCMS000	C0456079	atributo	3-8	610(0)_ANS_clinical_caseMIR	SENT1	-	-
3	en	en	SPS00	C1720294#C0332285	calificador#atributo	9-11	610(0)_ANS_clinical_caseMIR	SENT1	-	-
4	sangre	sangre	NCFS000	C0005767	sustancia	12-18	610(0)_ANS_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0332285	atributo	19-21	610(0)_ANS_clinical_caseMIR	SENT1	-	-
6	testosterona	testosterona	NCFS000	C0443483_1	sustancia_1	22-34	610(0)_ANS_clinical_caseMIR	SENT1	-	-
7	libre	libre	NCMS000	C0443483_2	sustancia_2	35-40	610(0)_ANS_clinical_caseMIR	SENT1	-	-
8	es	ser	VSIP3S0	-	-	41-43	610(0)_ANS_clinical_caseMIR	SENT1	-	-
9	predictor	predictor	AQ0MS0	-	-	44-53	610(0)_ANS_clinical_caseMIR	SENT1	-	-
10	del	del	SP+DA	-	-	54-57	610(0)_ANS_clinical_caseMIR	SENT1	-	-
11	éxito	éxito	NCMS000	-	-	58-63	610(0)_ANS_clinical_caseMIR	SENT1	-	-
12	terapéutico	terapéutico	AQ0MS0	-	-	64-75	610(0)_ANS_clinical_caseMIR	SENT1	-	-
13	de	de	SPS00	C0332285	atributo	76-78	610(0)_ANS_clinical_caseMIR	SENT1	-	-
14	la	el	DA0FS0	-	-	79-81	610(0)_ANS_clinical_caseMIR	SENT1	-	-
15	administración	administración	NCFS000	C1622419#C1533734#C0001554	procedimiento#concepto_para_navegación	82-96	610(0)_ANS_clinical_caseMIR	SENT1	-	-
16	exógena	exógeno	AQ0FS0	C0205228	calificador	97-104	610(0)_ANS_clinical_caseMIR	SENT1	-	-
17	de	de	SPS00	C0332285	atributo	105-107	610(0)_ANS_clinical_caseMIR	SENT1	-	-
18	andrógenos	andrógeno	NCMP000	C0002844	sustancia	108-118	610(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
19	.	.	Fp	-	-	119-120	610(0)_ANS_clinical_caseMIR	SENT1	-	-

